Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy

A Rabiolo, I Zucchiatti, A Marchese, G Baldin, R Sacconi, D Montorio, MV Cicinelli, L Querques, F Bandello, G Querques

Research output: Contribution to journalArticle

Abstract

Purpose - To correlate function and structural optical coherence tomography (OCT) to optical coherence tomography angiography (OCT-A) measures in patients affected by central serous chorioretinopathy (CSC) and to describe their changes after treatments (ie oral eplerenone, half-fluence photodynamic therapy (PDT)).Patients and methodsTwenty eyes of 16 consecutive patients with treatment-naïve CSC undergoing either eplerenone or PDT were enrolled in this prospective, observational study. All patients underwent structural OCT and OCT-A at baseline and after therapy at months 1 and 3.ResultsEleven eyes of nine patients and nine eyes of seven patients underwent eplerenone or PDT treatment, respectively. Central macular thickness (CMT) and subretinal fluid (SRF) correlated to fovea avascular zone (FAZ) area (r=0.74 and r=0.71, P=0.01) and vessel density (r=0.77 and r=0.68, P=0.01) at deep capillary plexus (DCP). CMT (P=0.0011), SRF (P=0.0005), SFCT (P=0.0016), FAZ area at DCP (P=0.0334) improved at 3-month visit. A significant reduction of deep FAZ area was appreciated in eplerenone (P=0.0204) but not in PDT (P=0.5) group. SFCT reduction was significantly higher in PDT than eplerenone group (P=0.0347).ConclusionStructural and vascular parameters are correlated in CSC and they improve after different treatments. Both half-fluence PDT and oral eplerenone do not permanently damage choriocapillaris or other choroidal layers as evaluated by OCT-A.
Original languageEnglish
Pages (from-to)55-66
Number of pages12
JournalEye (London, England)
Volume32
Issue number1
DOIs
Publication statusPublished - 2018

Fingerprint

Multimodal Imaging
Central Serous Chorioretinopathy
Photochemotherapy
Optical Coherence Tomography
Subretinal Fluid
Therapeutics
Observational Studies
Blood Vessels
eplerenone
Angiography
Prospective Studies

Cite this

Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy. / Rabiolo, A; Zucchiatti, I; Marchese, A; Baldin, G; Sacconi, R; Montorio, D; Cicinelli, MV; Querques, L; Bandello, F; Querques, G.

In: Eye (London, England), Vol. 32, No. 1, 2018, p. 55-66.

Research output: Contribution to journalArticle

Rabiolo, A, Zucchiatti, I, Marchese, A, Baldin, G, Sacconi, R, Montorio, D, Cicinelli, MV, Querques, L, Bandello, F & Querques, G 2018, 'Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy', Eye (London, England), vol. 32, no. 1, pp. 55-66. https://doi.org/10.1038/eye.2017.290
Rabiolo, A ; Zucchiatti, I ; Marchese, A ; Baldin, G ; Sacconi, R ; Montorio, D ; Cicinelli, MV ; Querques, L ; Bandello, F ; Querques, G. / Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy. In: Eye (London, England). 2018 ; Vol. 32, No. 1. pp. 55-66.
@article{513f5d408ca240a8a6328b79cc62c7d4,
title = "Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy",
abstract = "Purpose - To correlate function and structural optical coherence tomography (OCT) to optical coherence tomography angiography (OCT-A) measures in patients affected by central serous chorioretinopathy (CSC) and to describe their changes after treatments (ie oral eplerenone, half-fluence photodynamic therapy (PDT)).Patients and methodsTwenty eyes of 16 consecutive patients with treatment-na{\"i}ve CSC undergoing either eplerenone or PDT were enrolled in this prospective, observational study. All patients underwent structural OCT and OCT-A at baseline and after therapy at months 1 and 3.ResultsEleven eyes of nine patients and nine eyes of seven patients underwent eplerenone or PDT treatment, respectively. Central macular thickness (CMT) and subretinal fluid (SRF) correlated to fovea avascular zone (FAZ) area (r=0.74 and r=0.71, P=0.01) and vessel density (r=0.77 and r=0.68, P=0.01) at deep capillary plexus (DCP). CMT (P=0.0011), SRF (P=0.0005), SFCT (P=0.0016), FAZ area at DCP (P=0.0334) improved at 3-month visit. A significant reduction of deep FAZ area was appreciated in eplerenone (P=0.0204) but not in PDT (P=0.5) group. SFCT reduction was significantly higher in PDT than eplerenone group (P=0.0347).ConclusionStructural and vascular parameters are correlated in CSC and they improve after different treatments. Both half-fluence PDT and oral eplerenone do not permanently damage choriocapillaris or other choroidal layers as evaluated by OCT-A.",
author = "A Rabiolo and I Zucchiatti and A Marchese and G Baldin and R Sacconi and D Montorio and MV Cicinelli and L Querques and F Bandello and G Querques",
year = "2018",
doi = "10.1038/eye.2017.290",
language = "English",
volume = "32",
pages = "55--66",
journal = "Eye",
issn = "0950-222X",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy

AU - Rabiolo, A

AU - Zucchiatti, I

AU - Marchese, A

AU - Baldin, G

AU - Sacconi, R

AU - Montorio, D

AU - Cicinelli, MV

AU - Querques, L

AU - Bandello, F

AU - Querques, G

PY - 2018

Y1 - 2018

N2 - Purpose - To correlate function and structural optical coherence tomography (OCT) to optical coherence tomography angiography (OCT-A) measures in patients affected by central serous chorioretinopathy (CSC) and to describe their changes after treatments (ie oral eplerenone, half-fluence photodynamic therapy (PDT)).Patients and methodsTwenty eyes of 16 consecutive patients with treatment-naïve CSC undergoing either eplerenone or PDT were enrolled in this prospective, observational study. All patients underwent structural OCT and OCT-A at baseline and after therapy at months 1 and 3.ResultsEleven eyes of nine patients and nine eyes of seven patients underwent eplerenone or PDT treatment, respectively. Central macular thickness (CMT) and subretinal fluid (SRF) correlated to fovea avascular zone (FAZ) area (r=0.74 and r=0.71, P=0.01) and vessel density (r=0.77 and r=0.68, P=0.01) at deep capillary plexus (DCP). CMT (P=0.0011), SRF (P=0.0005), SFCT (P=0.0016), FAZ area at DCP (P=0.0334) improved at 3-month visit. A significant reduction of deep FAZ area was appreciated in eplerenone (P=0.0204) but not in PDT (P=0.5) group. SFCT reduction was significantly higher in PDT than eplerenone group (P=0.0347).ConclusionStructural and vascular parameters are correlated in CSC and they improve after different treatments. Both half-fluence PDT and oral eplerenone do not permanently damage choriocapillaris or other choroidal layers as evaluated by OCT-A.

AB - Purpose - To correlate function and structural optical coherence tomography (OCT) to optical coherence tomography angiography (OCT-A) measures in patients affected by central serous chorioretinopathy (CSC) and to describe their changes after treatments (ie oral eplerenone, half-fluence photodynamic therapy (PDT)).Patients and methodsTwenty eyes of 16 consecutive patients with treatment-naïve CSC undergoing either eplerenone or PDT were enrolled in this prospective, observational study. All patients underwent structural OCT and OCT-A at baseline and after therapy at months 1 and 3.ResultsEleven eyes of nine patients and nine eyes of seven patients underwent eplerenone or PDT treatment, respectively. Central macular thickness (CMT) and subretinal fluid (SRF) correlated to fovea avascular zone (FAZ) area (r=0.74 and r=0.71, P=0.01) and vessel density (r=0.77 and r=0.68, P=0.01) at deep capillary plexus (DCP). CMT (P=0.0011), SRF (P=0.0005), SFCT (P=0.0016), FAZ area at DCP (P=0.0334) improved at 3-month visit. A significant reduction of deep FAZ area was appreciated in eplerenone (P=0.0204) but not in PDT (P=0.5) group. SFCT reduction was significantly higher in PDT than eplerenone group (P=0.0347).ConclusionStructural and vascular parameters are correlated in CSC and they improve after different treatments. Both half-fluence PDT and oral eplerenone do not permanently damage choriocapillaris or other choroidal layers as evaluated by OCT-A.

U2 - 10.1038/eye.2017.290

DO - 10.1038/eye.2017.290

M3 - Article

VL - 32

SP - 55

EP - 66

JO - Eye

JF - Eye

SN - 0950-222X

IS - 1

ER -